Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease: A Meta-Analysis and Systematic Review

Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation... BackgroundThe effect of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) and liver disease remains largely unresolved. Therefore, we performed a meta-analysis to compare the efficacy and safety of NOACs with warfarin in this population.MethodsWe systematically searched the Cochrane Library, PubMed, and Embase databases for studies reporting the comparisons of NOACs with warfarin in patients with AF and liver disease. A random-effects model was selected to pool the risk ratios (RRs) and 95% confidence intervals (CIs).ResultsA total of six studies with 41,954 participants were included in this meta-analysis. In AF patients with liver disease, compared with warfarin use, the use of NOACs was associated with reduced risks of all-cause death (RR 0.78, 95% CI 0.66–0.93), major bleeding (RR 0.68, 95% CI 0.53–0.88), and intracranial hemorrhage (RR 0.49, 95% CI 0.41–0.59), but had comparable risks of stroke or system embolism (RR 0.80, 95% CI 0.57–1.12) and gastrointestinal bleeding (RR 0.90, 95% CI 0.61–1.34). In AF patients with cirrhosis, NOACs significantly reduced the risks of major bleeding (RR 0.53, 95% CI 0.37–0.76), gastrointestinal bleeding (RR 0.57, 95% CI 0.38–0.84), and intracranial hemorrhage (RR 0.55, 95% CI 0.31–0.97) compared with warfarin.ConclusionsBased on current publications, the use of NOACs is at least non-inferior to warfarin in patients with AF and liver disease. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cardiovascular Drugs Springer Journals

Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease: A Meta-Analysis and Systematic Review

Download PDF
9 pages

Loading next page...
 
/lp/springer-journals/non-vitamin-k-antagonist-oral-anticoagulants-versus-warfarin-in-D4J6wH0cxh

References (38)

  • R. Chokesuwattanaskul, C. Thongprayoon, T. Bathini, Aldo Torres-Ortiz, O. O'corragain, Kanramon Watthanasuntorn, P. Lertjitbanjong, Konika Sharma, S. Prechawat, P. Ungprasert, P. Kröner, K. Wijarnpreecha, W. Cheungpasitporn (2019)

    Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: A systematic review and meta-analysis.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 51 4

  • H. Heidbuchel, P. Verhamme, M. Alings, M. Antz, H. Diener, W. Hacke, J. Oldgren, P. Sinnaeve, A. Camm, Paulus Kirchhof, Paulus Kirchhof (2015)

    Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 17 10

  • Amanuel Abdulkader, A. Abajobir, K. Abate, C. Abbafati, K. Abbas, F. Abd-Allah, R. Abdulkader, A. Abdulle, Teshome Abebo, S. Abera, V. Aboyans, L. Abu-Raddad, I. Ackerman, Abdullahi Adamu, O. Adetokunboh, M. Afarideh, A. Afshin, Sachin Agarwal, Rakesh Aggarwal, Anurag Agrawal, S. Agrawal, H. Ahmadieh, M. Ahmed, Miloud Aichour, Amani Aichour, Ibtihel Aichour, Sneha Aiyar, R. Akinyemi, N. Akseer, F. Lami, Fares Alahdab, Z. Al‐Aly, K. Alam, N. Alam, Tahiya Alam, D. Alasfoor, K. Alene, R. Ali, R. Alizadeh-Navaei, A. Alkerwi, F. Alla, P. Allebeck, Christine Allen, F. Al-Maskari, Rajaa Al-Raddadi, U. Alsharif, S. Alsowaidi, K. Altirkawi, A. Amare, E. Amini, W. Ammar, Y. Amoako, H. Andersen, C. Antonio, P. Anwari, J. Ärnlöv, A. Artaman, K. Aryal, H. Asayesh, S. Asgedom, Reza Assadi, T. Atey, N. Atnafu, S. Atre, L. Ávila-Burgos, Euripide Avokphako, A. Awasthi, U. Bacha, A. Badawi, K. Balakrishnan, A. Banerjee, Marlena Bannick, A. Barać, Ryan Barber, S. Barker-Collo, T. Bärnighausen, S. Barquera, L. Barregard, L. Barrero, Sanjay Basu, Bob Battista, K. Battle, B. Baune, S. Bazargan-Hejazi, J. Beardsley, Neeraj Bedi, E. Beghi, Y. Béjot, Bayu Bekele, M. Bell, D. Bennett, I. Benseñor, Jennifer Benson, A. Berhane, D. Berhe, E. Bernabé, B. Betsu, M. Beuran, A. Beyene, N. Bhala, A. Bhansali, S. Bhatt, Z. Bhutta, S. Biadgilign, B. Bicer, Kelly Bienhoff, B. Bikbov, C. Birungi, S. Biryukov, D. Bisanzio, Habtamu Bizuayehu, D. Boneya, S. Boufous, R. Bourne, A. Brazinova, T. Brugha, R. Buchbinder, Lemma Bulto, Blair Bumgarner, Z. Butt, Lucero Cahuana-Hurtado, E. Cameron, M. Car, H. Carabin, J. Carapetis, Rosario Cárdenas, D. Carpenter, J. Carrero, A. Carter, F. Carvalho, Daniel Casey, V. Caso, C. Castañeda-Orjuela, Chris Castle, F. Catalá-López, Hsing-Yi Chang, Jung-Chen Chang, F. Charlson, Honglei Chen, Mirriam Chibalabala, C. Chibueze, V. Chisumpa, Abdulaal Chitheer, D. Christopher, Liliana Ciobanu, Massimo Cirillo, D. Colombara, C. Cooper, P. Cortesi, M. Criqui, J. Crump, A. Dadi, Koustuv Dalal, L. Dandona, R. Dandona, J. Neves, D. Davițoiu, B. Courten, D. Leo, B. Defo, L. Degenhardt, Selina Deiparine, R. Dellavalle, Kebede Deribe, D. Jarlais, Subhojit Dey, S. Dharmaratne, P. Dhillon, D. Dicker, E. Ding, Shirin Djalalinia, H. Do, E. Dorsey, Kadine Santos, D. Douwes-Schultz, Kerrie Doyle, T. Driscoll, Manisha Dubey, B. Duncan, Z. El-Khatib, Jerisha Ellerstrand, A. Enayati, A. Endries, S. Ermakov, H. Erskine, B. Eshrati, S. Eskandarieh, A. Esteghamati, Kara Estep, Fanuel Fanuel, C. Farinha, Andre Faro, F. Farzadfar, M. Fazeli, V. Feigin, S. Fereshtehnejad, João Catalão, A. Ferrari, T. Feyissa, I. Filip, F. Fischer, C. Fitzmaurice, A. Flaxman, L. Flor, N. Foigt, Kyle Foreman, R. Franklin, N. Fullman, Thomas Fürst, J. Furtado, N. Futran, E. Gakidou, M. Ganji, A. García-Basteiro, T. Gebre, T. Gebrehiwot, Ayele Geleto, Bikila Gemechu, H. Gesesew, P. Gething, A. Ghajar, K. Gibney, P. Gill, R. Gillum, I. Ginawi, A. Giref, Melkamu Gishu, G. Giussani, W. Godwin, Audra Gold, Ellen Goldberg, P. Gona, A. Goodridge, S. Gopalani, A. Goto, A. Goulart, Max Griswold, H. Gugnani, Rahul Gupta, R. Gupta, Tanush Gupta, Vipin Gupta, N. Hafezi-Nejad, G. Hailu, A. Hailu, R. Hamadeh, S. Hamidi, A. Handal, G. Hankey, S. Hanson, Yuantao Hao, H. Harb, H. Hareri, J. Haro, James Harvey, Mohammad Hassanvand, Rasmus Havmoeller, Caitlin Hawley, S. Hay, Roderick Hay, N. Henry, I. Heredia-Pi, J. Hernandez, P. Heydarpour, H. Hoek, Howard Hoffman, N. Horita, H. Hosgood, S. Hostiuc, P. Hotez, D. Hoy, A. Htet, G. Hu, Hsiang Huang, Chantal Huynh, K. Iburg, E. Igumbor, C. Ikeda, C. Irvine, K. Jacobsen, N. Jahanmehr, Mihajlo Jakovljevic, Simerjot Jassal, Mehdi Javanbakht, S. Jayaraman, P. Jeemon, P. Jensen, Vivekanand Jha, G. Jiang, D. John, Sarah Johnson, C. Johnson, J. Jonas, Mikk Jürisson, Z. Kabir, R. Kadel, Amaha Kahsay, R. Kamal, Haidong Kan, Nadim Karam, A. Karch, C. Karema, A. Kasaeian, G. Kassa, N. Kassaw, N. Kassebaum, A. Kastor, S. Katikireddi, Anil Kaul, N. Kawakami, P. Keiyoro, A. Kengne, A. Keren, Yousef Khader, I. Khalil, E. Khan, Y. Khang, A. Khosravi, J. Khubchandani, A. Kiadaliri, C. Kieling, Y. Kim, Daniel Kim, Pauline Kim, R. Kimokoti, Y. Kinfu, A. Kisa, K. Kissimova-Skarbek, M. Kivimaki, A. Knudsen, Y. Kokubo, D. Kolte, J. Kopec, S. Kosen, P. Koul, A. Koyanagi, M. Kravchenko, S. Krishnaswami, Kristopher Krohn, G. Kumar, Pushpendra Kumar, Surinder Kumar, H. Kyu, D. Lal, R. Lalloo, Nkurunziza Lambert, Q. Lan, A. Larsson, P. Lavados, J. Leasher, P. Lee, Jong-Tae Lee, J. Leigh, C. Leshargie, J. Leung, R. Leung, M. Levi, Yichong Li, Yongmei Li, Darya Kappe, Xiaofeng Liang, Misgan Liben, Stephen Lim, S. Linn, Patrick Liu, Angela Liu, Shiwei Liu, Yang Liu, R. Lodha, G. Logroscino, S. London, K. Looker, Alan Lopez, S. Lorkowski, P. Lotufo, N. Low, R. Lozano, T. Lucas, Erlyn Macarayan, H. Razek, M. Razek, M. Mahdavi, M. Majdan, R. Majdzadeh, A. Majeed, R. Malekzadeh, R. Malhotra, D. Malta, A. Mamun, Helena Manguerra, Treh Manhertz, Ana Mantilla, L. Mantovani, C. Mapoma, L. Marczak, J. Martínez-Raga, Francisco Martins-Melo, Ira Martopullo, Winfried März, M. Mathur, M. Mazidi, C. McAlinden, Madeline McGaughey, J. Mcgrath, M. McKee, C. McNellan, S. Mehata, M. Mehndiratta, T. Mekonnen, P. Memiah, Z. Memish, W. Mendoza, Mubarek Mengistie, D. Mengistu, G. Mensah, T. Meretoja, A. Meretoja, H. Mezgebe, R. Micha, Anoushka Millear, Ted Miller, Edward Mills, M. Mirarefin, E. Mirrakhimov, A. Misganaw, S. Mishra, P. Mitchell, K. Mohammad, A. Mohammadi, K. Mohammed, S. Mohammed, S. Mohanty, A. Mokdad, Sarah Mollenkopf, L. Monasta, M. Montico, M. Moradi-Lakeh, P. Moraga, R. Mori, C. Morozoff, S. Morrison, Mark Moses, Cliff Mountjoy-Venning, K. Mruts, U. Mueller, Kate Muller, M. Murdoch, C. Murray, G. Murthy, K. Musa, J. Nachega, G. Nagel, M. Naghavi, A. Naheed, K. Naidoo, L. Naldi, V. Nangia, G. Natarajan, Dumessa Negasa, R. Negoi, I. Negoi, C. Newton, J. Ngunjiri, T. Nguyen, Q. Nguyen, Cuong Nguyen, Grant Nguyen, Minh Nguyen, E. Nichols, D. Ningrum, Sandra Nolte, V. Nong, B. Norrving, J. Noubiap, Martin O'Donnell, F. Ogbo, I. Oh, Anselm Okoro, O. Oladimeji, T. Olagunju, A. Olagunju, H. Olsen, B. Olusanya, J. Olusanya, K. Ong, John Opio, Eyal Oren, Alberto Ortiz, Aaron Osgood-Zimmerman, M. Osman, M. Owolabi, Mahesh Pa, R. Pacella, A. Pana, B. Panda, C. Papachristou, Eun Park, C. Parry, M. Parsaeian, S. Patten (2017)

    Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

    Lancet (London, England), 390

  • A. Tripodi, S. Caldwell, M. Hoffman, J. Trotter, A. Sanyal (2007)

    Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease

    Alimentary Pharmacology & Therapeutics, 26

  • D. Pastori, G. Lip, A. Farcomeni, Francesco Sole, A. Sciacqua, F. Perticone, R. Marcucci, E. Grifoni, P. Pignatelli, F. Violi, M. Saliola, M. Casciaro, D. Menichelli, F. Cribari, A. Paladino, Rony Gingis, M. Novo, V. Cammisotto, C. Nocella, S. Bartimoccia, R. Carnevale, Tiziana Stefano, P. Iannucci, E. Sabbatini, L. Anastasio, Joseph Eliezer (2018)

    Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.

    International journal of cardiology, 264

  • L. Kuo, T. Chao, Chia-Jen Liu, Yenn-Jiang Lin, S. Chang, L. Lo, Yu-Feng Hu, Ta-Chuan Tuan, J. Liao, F. Chung, Tzeng-Ji Chen, G. Lip, Shih‐Ann Chen (2017)

    Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 6

  • Pavel Goriacko, Keith Veltri (2018)

    Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation

    European Journal of Haematology, 100

  • So-Ryoung Lee, Hyun-Jung Lee, E. Choi, Kyungdo Han, Jin-Hyung Jung, M. Cha, Seil Oh, G. Lip (2019)

    Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease.

    Journal of the American College of Cardiology, 73 25

  • P. Kirchhof, S. Benussi, D. Kotecha, A. Ahlsson, D. Atar, B. Casadei, M. Castellà, H. Diener, H. Heidbuchel, J. Hendriks, G. Hindricks, A. Manolis, J. Oldgren, B. Popescu, U. Schotten, B. putte, P. Vardas (2016)

    2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

    European heart journal, 37 38

  • A. Tripodi, P. Mannucci (2011)

    The coagulopathy of chronic liver disease.

    The New England journal of medicine, 365 2

  • E. Hylek, F. Anania (2019)

    Oral Anticoagulants in Liver Disease: Not Child's Play.

    Journal of the American College of Cardiology, 73 25

  • P. Kirchhof, S. Benussi, D. Kotecha, A. Ahlsson, D. Atar, B. Casadei, M. Castellà, H. Diener, H. Heidbuchel, J. Hendriks, G. Hindricks, A. Manolis, J. Oldgren, B. Popescu, U. Schotten, B. putte, P. Vardas (2016)

    [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS].

    Kardiologia polska, 74 12

  • P. Kirchhof, S. Benussi, D. Kotecha, A. Ahlsson, D. Atar, B. Casadei, M. Castellà, H. Diener, H. Heidbuchel, J. Hendriks, G. Hindricks, A. Manolis, J. Oldgren, B. Popescu, U. Schotten, B. putte, P. Vardas, S. Agewall, J. Camm, G. Esquivias, W. Budts, S. Carerj, F. Casselman, A. Coca, R. Caterina, S. Deftereos, D. Dobrev, J. Ferro, G. Filippatos, D. Fitzsimons, B. Gorenek, M. Guenoun, S. Hohnloser, P. Kolh, G. Lip, A. Manolis, J. McMurray, P. Ponikowski, R. Rosenhek, F. Ruschitzka, I. Savelieva, Sanjay Sharma, P. Suwalski, J. Tamargo, C. Taylor, I. Gelder, A. Voors, S. Windecker, J. Zamorano, K. Zeppenfeld (2016)

    2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 18 11

  • A. Stang (2010)

    Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

    European Journal of Epidemiology, 25

  • D. Pastori, G. Lip, A. Farcomeni, Francesco Sole, A. Sciacqua, F. Perticone, R. Marcucci, E. Grifoni, P. Pignatelli, F. Violi, Mirella Gingi, M. Saliola, M. Casciaro, D. Menichelli, F. Cribari, A. Paladino, Rony Gingis, M. Novo, V. Cammisotto, C. Nocella, S. Bartimoccia, R. Carnevale, Tiziana Stefano, P. Iannucci, E. Sabbatini, L. Anastasio, Joseph Eliezer (2018)

    Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants

    Data in Brief, 17

  • M. Patel, K. Mahaffey, Jyotsna Garg, Guohua Pan, D. Singer, W. Hacke, G. Breithardt, J. Halperin, G. Hankey, J. Piccini, R. Becker, C. Nessel, J. Paolini, S. Berkowitz, K. Fox, R. Califf (2011)

    Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

    The New England journal of medicine, 365 10

  • C. Gallagher, P. Sanders, Christopher Wong (2019)

    Anticoagulation for Atrial Fibrillation in Cirrhosis of the Liver: Are Low‐Dose Non‐Vitamin K Oral Anticoagulants a Reasonable Alternative to Warfarin?

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 8

  • Christopher Granger, J. Alexander, John McMurray, R. Lopes, E. Hylek, M. Hanna, H. Al-Khalidi, J. Ansell, D. Atar, Á. Avezum, M. Bahit, Rafael Diaz, J. Easton, J. Ezekowitz, Greg Flaker, David Garcia, M. Geraldes, B. Gersh, S. Golitsyn, S. Goto, A. Hermosillo, S. Hohnloser, John Horowitz, Puneet Mohan, P. Janský, Basil Lewis, J. López-Sendón, P. Pais, A. Parkhomenko, F. Verheugt, Jun Zhu, L. Wallentin (2011)

    Apixaban versus warfarin in patients with atrial fibrillation.

    The New England journal of medicine, 365 11

  • Hsin-Fu Lee, Y. Chan, Shang-Hung Chang, H. Tu, Shao‐Wei Chen, Yung-Hsin Yeh, Lung‐Sheng Wu, Chang-Fu Kuo, C. Kuo, L. See (2019)

    Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 8

  • Yun-Jiu Cheng, X. Nie, Xu‐Miao Chen, Xiao‐Xiong Lin, Kaiyu Tang, W. Zeng, Wei-yi Mei, Li-Juan Liu, Ming Long, Fengjuan Yao, Jun Liu, Xin-xue Liao, Z. Du, Yu-gang Dong, Hong Ma, Haipeng Xiao, Su‐Hua Wu (2015)

    The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk.

    Journal of the American College of Cardiology, 66 20

  • C. January, L. Wann, Hugh Calkins, Lin Chen, Joaquin Cigarroa, Joseph Cleveland, P. Ellinor, M. Ezekowitz, Michael Field, K. Furie, P. Heidenreich, Katherine Murray, Julie Shea, C. Tracy, C. Yancy (2019)

    2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

    Journal of the American College of Cardiology

  • Lydia Efird, D. Mishkin, D. Berlowitz, A. Ash, E. Hylek, A. Ozonoff, J. Reisman, Shibei Zhao, G. Jasuja, A. Rose (2014)

    Stratifying the Risks of Oral Anticoagulation in Patients With Liver Disease

    Circulation: Cardiovascular Quality and Outcomes, 7

  • P. Northup (2009)

    Hypercoagulation in liver disease.

    Clinics in liver disease, 13 1

  • C. January, L. Wann, J. Alpert, H. Calkins, J. Cigarroa, J. Cleveland, J. Conti, P. Ellinor, M. Ezekowitz, M. Field, K. Murray, R. Sacco, W. Stevenson, P. Tchou, C. Tracy, C. Yancy (2014)

    2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

    Circulation, 130 23

  • E. Benjamin, P. Muntner, Á. Alonso, M. Bittencourt, C. Callaway, A. Carson, A. Chamberlain, Alexander Chang, Susan Cheng, Sandeep Das, F. Delling, L. Djoussé, M. Elkind, J. Ferguson, M. Fornage, L. Jordan, S. Khan, B. Kissela, K. Knutson, T. Kwan, D. Lackland, T. Lewis, J. Lichtman, C. Longenecker, M. Loop, P. Lutsey, S. Martin, K. Matsushita, Andrew Moran, M. Mussolino, M. O’Flaherty, A. Pandey, A. Perak, W. Rosamond, Gregory Roth, Uchechukwu Sampson, G. Satou, Emily Schroeder, Svati Shah, Nicole Spartano, A. Stokes, D. Tirschwell, C. Tsao, M. Turakhia, L. VanWagner, J. Wilkins, Sally Wong, S. Virani (2019)

    Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association

    Circulation, 139

  • Spencer Abbastabar, S. James, D. Abate, K. Abate, Solomon Abay, C. Abbafati, Nooshin Abbasi, H. Abbastabar, F. Abd-Allah, Jemal Abdela, A. Abdelalim, Ibrahim Abdollahpour, R. Abdulkader, Zegeye Abebe, S. Abera, Olifan Abil, H. Abraha, L. Abu-Raddad, Niveen Abu-Rmeileh, Manfred Accrombessi, Dilaram Acharya, Pawan Acharya, Ilana Ackerman, Abdullahi Adamu, O. Adebayo, V. Adekanmbi, O. Adetokunboh, Mina Adib, Jose Adsuar, K. Afanvi, Mohsen Afarideh, A. Afshin, Gina Agarwal, Kareha Agesa, Rakesh Aggarwal, S. Aghayan, S. Agrawal, Alireza Ahmadi, Mehdi Ahmadi, H. Ahmadieh, M. Ahmed, Amani Aichour, Ibtihel Aichour, Miloud Aichour, Tomi Akinyemiju, N. Akseer, Z. Al‐Aly, A. Al-Eyadhy, Hesham Al-Mekhlafi, Rajaa Al-Raddadi, Fares Alahdab, K. Alam, Tahiya Alam, Alaa Alashi, S. Alavian, K. Alene, M. Alijanzadeh, R. Alizadeh-Navaei, S. Aljunid, A. Alkerwi, François Alla, Peter Allebeck, Mohamed Alouani, K. Altirkawi, N. Alvis-Guzmán, A. Amare, L. Aminde, W. Ammar, Y. Amoako, N. Anber, C. Andrei, S. Androudi, Megbaru Animut, Mina Anjomshoa, Mustafa Ansha, C. Antonio, P. Anwari, J. Arabloo, Antonio Arauz, O. Aremu, F. Ariani, Bahroom Armoon, Johan Ärnlöv, Amit Arora, A. Artaman, K. Aryal, H. Asayesh, R. Asghar, Z. Ataro, Sachin Atre, M. Ausloos, L. Ávila-Burgos, Euripide Avokpaho, A. Awasthi, B. Quintanilla, R. Ayer, P. Azzopardi, A. Babazadeh, Hamid Badali, A. Badawi, A. Bali, Katherine Ballesteros, S. Ballew, Maciej Banach, J. Banoub, A. Banstola, A. Barać, Miguel Barboza, S. Barker-Collo, T. Bärnighausen, L. Barrero, B. Baune, S. Bazargan-Hejazi, Neeraj Bedi, Ettore Beghi, Masoud Behzadifar, M. Behzadifar, Yannick Béjot, A. Belachew, Yihalem Belay, Michelle Bell, A. Bello, Isabela Bensenor, Eduardo Bernabé, Robert Bernstein, M. Beuran, Tina Beyranvand, N. Bhala, S. Bhattarai, Soumyadeep Bhaumik, Z. Bhutta, B. Biadgo, A. Bijani, B. Bikbov, V. Bilano, Nigus Bililign, M. Sayeed, D. Bisanzio, B. Blacker, Fiona Blyth, I. Bou-Orm, S. Boufous, R. Bourne, Oliver Brady, Michael Brainin, L. Brant, A. Brazinova, N. Breitborde, Hermann Brenner, P. Briant, Andrew Briggs, A. Briko, Gabrielle Britton, T. Brugha, Rachelle Buchbinder, Reinhard Busse, Z. Butt, Lucero Cahuana-Hurtado, Jorge Cano, Rosario Cárdenas, J. Carrero, A. Carter, F. Carvalho, C. Castañeda-Orjuela, Jacqueline Rivas, Franz Castro, Ferrán Catalá-López, Kelly Cercy, Ester Cerin, Y. Chaiah, Alex Chang, Hsing-Yi Chang, Jung-Chen Chang, F. Charlson, Aparajita Chattopadhyay, Vijay Chattu, Pankaj Chaturvedi, P. Chiang, Ken Chin, Abdulaal Chitheer, J. Choi, Rajiv Chowdhury, H. Christensen, D. Christopher, F. Cicuttini, Liliana Ciobanu, Massimo Cirillo, R. Claro, D. Collado-Mateo, Cyrus Cooper, Josef Coresh, P. Cortesi, Monica Cortinovis, Megan Costa, Ewerton Cousin, M. Criqui, Elizabeth Cromwell, M. Cross, J. Crump, A. Dadi, L. Dandona, R. Dandona, Paul Dargan, A. Daryani, R. Gupta, J. Neves, T. Dasa, Gail Davey, A. Davis, D. Davițoiu, B. Courten, Fernando Hoz, Diego Leo, Jan‐Walter Neve, M. Degefa, L. Degenhardt, Selina Deiparine, R. Dellavalle, Gebre Demoz, Kebede Deribe, N. Dervenis, Don Jarlais, Getenet Dessie, Subhojit Dey, S. Dharmaratne, Mesfin Dinberu, M. Dirac, Shirin Djalalinia, L. Doan, K. Dokova, D. Doku, E. Dorsey, Kerrie Doyle, T. Driscoll, M. Dubey, E. Dubljanin, Eyasu Duken, Bruce Duncan, A. Durães, H. Ebrahimi, S. Ebrahimpour, M. Echko, D. Edvardsson, A. Effiong, Joshua Ehrlich, C. Bcheraoui, M. Zaki, Z. El-Khatib, H. Elkout, Iqbal Elyazar, A. Enayati, A. Endries, Benjamin Er, H. Erskine, B. Eshrati, S. Eskandarieh, Alireza Esteghamati, S. Esteghamati, H. Fakhim, Vahid Omrani, Mahbobeh Faramarzi, M. Fareed, F. Farhadi, Talha Farid, C. Farinha, Andrea Farioli, Andre Faro, M. Farvid, F. Farzadfar, Valery Feigin, Netsanet Fentahun, S. Fereshtehnejad, Eduarda Fernandes, Joao Fernandes, A. Ferrari, Garumma Feyissa, I. Filip, Florian Fischer, C. Fitzmaurice, N. Foigt, Kyle Foreman, Jack Fox, Tahvi Frank, Takeshi Fukumoto, N. Fullman, Thomas Fürst, João Furtado, Neal Futran, S. Gall, M. Ganji, F. Gankpé, A. García-Basteiro, William Gardner, A. Gebre, A. Gebremedhin, Teklu Gebremichael, Tilayie Gelano, J. Geleijnse, R. Gènova-Maleras, Y. Geramo, P. Gething, Kebede Gezae, K. Ghadiri, Khalil Falavarjani, M. Ghasemi-Kasman, M. Ghimire, Rakesh Ghosh, A. Ghoshal, Simona Giampaoli, P. Gill, Tiffany Gill, I. Ginawi, G. Giussani, E. Gnedovskaya, Ellen Goldberg, Srinivas Goli, H. Gómez-Dantés, P. Gona, S. Gopalani, Taren Gorman, A. Goulart, B. Goulart, A. Grada, Morgan Grams, Giuseppe Grosso, H. Gugnani, Yuming Guo, Prakash Gupta, Rahul Gupta, R. Gupta, Tanush Gupta, Bishal Gyawali, J. Haagsma, Vladimir Hachinski, N. Hafezi-Nejad, Hassan Bidgoli, Tekleberhan Hagos, G. Hailu, Arvin Haj-Mirzaian, A. Haj-Mirzaian, R. Hamadeh, S. Hamidi, A. Handal, Graeme Hankey, Yuantao Hao, H. Harb, Sivadasanpillai Harikrishnan, J. Haro, M. Hasan, H. Hassankhani, H. Hassen, Rasmus Havmoeller, Caitlin Hawley, Roderick Hay, S. Hay, A. Hedayatizadeh-Omran, B. Heibati, D. Hendrie, A. Henok, C. Herteliu, S. Heydarpour, D. Hibstu, Huong Hoang, Hans Hoek, Howard Hoffman, M. Hole, Enayatollah Rad, Praveen Hoogar, H. Hosgood, Seyed Hosseini, M. Hosseinzadeh, M. Hostiuc, S. Hostiuc, Peter Hotez, D. Hoy, M. Hsairi, A. Htet, Guoqing Hu, John Huang, Chantal Huynh, K. Iburg, C. Ikeda, B. Ileanu, O Ilesanmi, Usman Iqbal, S. Irvani, C. Irvine, Sheikh Islam, F. Islami, K. Jacobsen, L. Jahangiry, N. Jahanmehr, Sudhir Jain, Mihajlo Jakovljevic, Mehdi Javanbakht, A. Jayatilleke, P. Jeemon, Ravi Jha, Vivekanand Jha, John Ji, C. Johnson, J. Jonas, J. Jozwiak, Suresh Jungari, Mikk Jürisson, Zubair Kabir, R. Kadel, Amaha Kahsay, Rizwan Kalani, T. Kanchan, Manoochehr Karami, B. Matin, André Karch, C. Karema, Narges Karimi, Seyed Karimi, A. Kasaeian, D. Kassa, G. Kassa, T. Kassa, N. Kassebaum, S. Katikireddi, Norito Kawakami, Ali Karyani, Masoud Keighobadi, P. Keiyoro, L. Kemmer, Grant Kemp, A. Kengne, Andre Keren, Yousef Khader, Behzad Khafaei, M. Khafaie, Alireza Khajavi, I. Khalil, E. Khan, Muhammad Khan, Muhammad Khan, Y. Khang, Mohammad Khazaei, Abdullah Khoja, A. Khosravi, Mohammad Khosravi, A. Kiadaliri, Daniel Kiirithio, Cho-il Kim, Daniel Kim, Pauline Kim, Young-Eun Kim, Yun Kim, R. Kimokoti, Y. Kinfu, A. Kisa, K. Kissimova-Skarbek, Mika Kivimäki, A. Knudsen, Jonathan Kocarnik, S. Kochhar, Yoshihiro Kokubo, T. Kolola, Jacek Kopec, S. Kosen, Georgios Kotsakis, P. Koul, Ai Koyanagi, M. Kravchenko, K. Krishan, Kristopher Krohn, B. Defo, B. Bicer, G. Kumar, Manasi Kumar, H. Kyu, Deepesh Lad, S. Lad, A. Lafranconi, R. Lalloo, T. Lallukka, Faris Lami, V. Lansingh, A. Latifi, Kathryn Lau, Jeffrey Lazarus, J. Leasher, J. Ledesma, P. Lee, J. Leigh, Janni Leung, Miriam Levi, S. Lewycka, Shanshan Li, Yichong Li, Yu Liao, Misgan Liben, Lee-Ling Lim, Stephen Lim, Shiwei Liu, R. Lodha, Katharine Looker, A. Lopez (2018)

    Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Lancet (London, England), 392

  • E. Hoolwerf, N. Kraaijpoel, H. Büller, N. Es (2018)

    Direct oral anticoagulants in patients with liver cirrhosis: A systematic review.

    Thrombosis research, 170

  • Arman Qamar, M. Vaduganathan, N. Greenberger, R. Giugliano (2018)

    Oral Anticoagulation in Patients With Liver Disease.

    Journal of the American College of Cardiology, 71 19

  • C. January, L. Wann, Joseph Alpert, H. Calkins, Joaquin Cigarroa, Joseph Cleveland, Jamie Conti, P. Ellinor, M. Ezekowitz, Michael Field, Katherine Murray, Ralph Sacco, William Stevenson, Patrick Tchou, C. Tracy, C. Yancy (2014)

    2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

    Circulation, 130 23

  • R. Giugliano, C. Ruff, E. Braunwald, S. Murphy, S. Wiviott, J. Halperin, A. Waldo, M. Ezekowitz, J. Weitz, J. Špinar, W. Rużyłło, M. Ruda, Y. Koretsune, Joshua Betcher, M. Shi, L. Grip, Shirali Patel, Indravadan Patel, J. Hanyok, M. Mercuri, E. Antman (2013)

    Edoxaban versus warfarin in patients with atrial fibrillation.

    The New England journal of medicine, 369 22

  • N. Holford (1986)

    Clinical Pharmacokinetics and Pharmacodynamics of Warfarin

    Clinical Pharmacokinetics, 11

  • S. Connolly, M. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P. Reilly, E. Themeles, Jeanne Varrone, Susan Wang, M. Alings, D. Xavier, Jun Zhu, R. Diaz, B. Lewis, H. Darius, H. Diener, C. Joyner, L. Wallentin (2009)

    Dabigatran versus warfarin in patients with atrial fibrillation.

    The New England journal of medicine, 361 12

  • Chun-Li Wang, V. Wu, C. Kuo, P. Chu, Hsiao-Jung Tseng, M. Wen, Shang-Hung Chang (2018)

    Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 7

  • S. Doi, J. Barendregt, Shahjahan Khan, L. Thalib, Gail Williams (2015)

    Advances in the meta-analysis of heterogeneous clinical trials II: The quality effects model.

    Contemporary clinical trials, 45 Pt A

  • J. Steffel, P. Verhamme, T. Potpara, P. Albaladéjo, M. Antz, L. Desteghe, K. Haeusler, J. Oldgren, H. Reinecke, V. Roldán-Schilling, N. Rowell, P. Sinnaeve, R. Collins, A. Camm, H. Heidbüchel, G. Lip, J. Weitz, L. Fauchier, D. Lane, G. Boriani, A. Goette, R. Keegan, R. Macfadyen, C. Chiang, B. Joung, W. Shimizu (2018)

    The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

    European heart journal, 39 16

  • C. Ruff, R. Giugliano, E. Braunwald, Elaine Hoffman, Naveen Deenadayalu, M. Ezekowitz, A. Camm, J. Weitz, Basil Lewis, A. Parkhomenko, T. Yamashita, E. Antman (2014)

    Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

    The Lancet, 383

  • Benjamin Fox, Susan Kahn, David Langleben, Mark Eisenberg, A. Shimony (2012)

    Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials

    The BMJ, 345

  • Arman Qamar, E. Antman, C. Ruff, F. Nordio, S. Murphy, L. Grip, N. Greenberger, O. Yin, Youngsook Choi, H. Lanz, M. Mercuri, E. Braunwald, R. Giugliano (2019)

    Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease.

    Journal of the American College of Cardiology, 74 2

Publisher
Springer Journals
Copyright
Copyright © Springer Nature Switzerland AG 2019
Subject
Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
ISSN
1175-3277
eISSN
1179-187X
DOI
10.1007/s40256-019-00369-x
Publisher site
See Article on Publisher Site

Abstract

BackgroundThe effect of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) and liver disease remains largely unresolved. Therefore, we performed a meta-analysis to compare the efficacy and safety of NOACs with warfarin in this population.MethodsWe systematically searched the Cochrane Library, PubMed, and Embase databases for studies reporting the comparisons of NOACs with warfarin in patients with AF and liver disease. A random-effects model was selected to pool the risk ratios (RRs) and 95% confidence intervals (CIs).ResultsA total of six studies with 41,954 participants were included in this meta-analysis. In AF patients with liver disease, compared with warfarin use, the use of NOACs was associated with reduced risks of all-cause death (RR 0.78, 95% CI 0.66–0.93), major bleeding (RR 0.68, 95% CI 0.53–0.88), and intracranial hemorrhage (RR 0.49, 95% CI 0.41–0.59), but had comparable risks of stroke or system embolism (RR 0.80, 95% CI 0.57–1.12) and gastrointestinal bleeding (RR 0.90, 95% CI 0.61–1.34). In AF patients with cirrhosis, NOACs significantly reduced the risks of major bleeding (RR 0.53, 95% CI 0.37–0.76), gastrointestinal bleeding (RR 0.57, 95% CI 0.38–0.84), and intracranial hemorrhage (RR 0.55, 95% CI 0.31–0.97) compared with warfarin.ConclusionsBased on current publications, the use of NOACs is at least non-inferior to warfarin in patients with AF and liver disease.

Journal

American Journal of Cardiovascular Drugs – Springer Journals

Published: Apr 4, 2020

There are no references for this article.